gp100 (174-190)

gp100 (174-190) is a synthetic peptide fragment derived from the human glycoprotein 100 (gp100), a melanosomal antigen extensively studied in the context of immunological recognition and melanoma research. As a defined epitope corresponding to amino acids 174 to 190 of the gp100 protein, this peptide is widely utilized in immunological assays and cellular studies to probe antigen-specific responses, particularly those involving cytotoxic T lymphocytes (CTLs) and major histocompatibility complex (MHC) interactions. Its well-characterized sequence and immunogenic properties make it a valuable tool for dissecting the molecular mechanisms underlying antigen processing, presentation, and T cell activation in both basic and translational research settings.

Epitope mapping: The 174-190 fragment of gp100 serves as a precise model epitope for mapping T cell recognition sites within the larger glycoprotein. Researchers employ this peptide to delineate the specificity and diversity of T cell receptor (TCR) engagement, allowing for a detailed understanding of immune surveillance mechanisms in the context of melanocytic antigens. By presenting the peptide in vitro to T cells or antigen-presenting cells, investigators can characterize the fine specificity of immune responses and identify immunodominant regions critical for antigenicity.

Immunogenicity assessment: In vitro systems frequently utilize this peptide to evaluate the immunogenic potential of gp100-derived epitopes. The defined sequence enables controlled studies on T cell priming, proliferation, and cytokine release in response to peptide stimulation. Such applications are instrumental in optimizing peptide-based immunological assays, validating the immunogenicity of candidate antigens, and supporting the development of novel strategies for immune monitoring in research models.

MHC binding studies: The gp100 (174-190) peptide is commonly used to investigate peptide-MHC class I and class II binding affinities and stability. By loading the peptide onto isolated MHC molecules or engineered cell lines, researchers can systematically examine the molecular determinants of antigen presentation and the influence of sequence variation on MHC-peptide complex formation. These experiments are crucial for elucidating the structural basis of antigen recognition and for guiding the rational design of immunological reagents.

T cell activation assays: Experimental protocols often incorporate this peptide as a stimulus to activate antigen-specific T cells, enabling the assessment of cellular responses such as cytotoxicity, cytokine production, and proliferation. These assays provide quantitative and qualitative data on the functional capacity of T cell populations, supporting investigations into T cell receptor signaling, immune modulation, and the evaluation of immune interventions in preclinical models.

Peptide-based assay development: The defined structure and immunological relevance of the gp100 (174-190) sequence facilitate the development of sensitive and specific peptide-based assays. It is widely used in enzyme-linked immunospot (ELISpot), intracellular cytokine staining, and multimer staining protocols to detect and quantify antigen-specific T cells. The peptide's role in these platforms supports high-throughput screening, immune monitoring, and the validation of immunological reagents in a variety of research contexts, advancing the study of antigen-specific immune responses.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. High fat diet and GLP-1 drugs induce pancreatic injury in mice

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction